Fisher & Paykel Healthcare Corporation Limited(NZ:FPH)
NZ$48.54+0.56 (+0.19%)
NZ:FPH
Fisher & Paykel Healthcare Corporation Limited stock forecast
NZ$48.54
At close:+0.56 (+0.19%)
Want to see NZ:FPH full AI Analyst Report?
Fisher & Paykel Healthcare Corporation Limited (FPH) Stock Forecast & Price Target
3 Followers
FPH Analyst Ratings
Strong Buy
6Buy2Hold0Sell
Based on 8 analysts giving stock ratings to Fisher & Paykel Healthcare Corporation Limited in the past 3 months
FPH Stock 12 Month Forecast
Average Price Target
NZD 52.97▲(9.12% Upside)Based on 8 Wall Street analysts offering 12 month price targets for Fisher & Paykel Healthcare Corporation Limited in the last 3 months. The average price target is NZD 52.97 with a high forecast of NZD 56.88 and a low forecast of NZD 51.00. The average price target represents a 9.12% change from the last price of NZD 48.54.
Past 12 Months12 Month ForecastJan2026Oct2026
HighNZD 56.88
AverageNZD 52.97
LowNZD 51.00
Highest Price TargetHighestNZD 56.88Average Price TargetNZD 52.97Lowest Price TargetLowestNZD 51.00
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Marcus Curley | UBS | NZD 42→NZD 51 | hold | 5.07%Upside | Reiterated | 11/04/26 | ||
| Vanessa Thomson | Jefferies | NZD 52.84→NZD 56.88 | buy | 17.18%Upside | Reiterated | 10/29/26 | ||
| Craig Wong-Pan | RBC Capital | NZD 39→NZD 52 | buy | 7.13%Upside | Upgraded | 09/15/26 | ||
| Laura Sutcliffe | Citi | NZD 40→NZD 51 | buy | 5.07%Upside | Upgraded | 09/10/26 | ||
| David Bailey | Morgan Stanley | ― | buy | ― | Reiterated | 08/24/26 | ||
| Adrian Allbon | Jarden | ― | hold | ― | Reiterated | 08/24/26 | ||
| Chris Cooper | J.P. Morgan | NZD 53.96 | buy | 11.16%Upside | Reiterated | 08/24/26 | ||
 Unknown AnalystNot Ranked | Macquarie | ― | buy | ― | Reiterated | 08/23/26 | ||
| Shane Storey | Canaccord Genuity | NZD 45.38 | buy | -6.51%Downside | Reiterated | 05/27/26 | ||
| Davinthra Thillainathan | Goldman Sachs | NZD 53.21→NZD 54.83 | buy | 12.96%Upside | Reiterated | 02/23/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Marcus CurleyUBS | HoldReiteratedNZD 42→NZD 51 | 11/04/26 | 5.07%Upside | ||
| Vanessa ThomsonJefferies | BuyReiteratedNZD 52.84→NZD 56.88 | 10/29/26 | 17.18%Upside | ||
| Craig Wong-PanRBC Capital | BuyUpgradedNZD 39→NZD 52 | 09/15/26 | 7.13%Upside | ||
| Laura SutcliffeCiti | BuyUpgradedNZD 40→NZD 51 | 09/10/26 | 5.07%Upside | ||
| David BaileyMorgan Stanley | BuyReiterated | 08/24/26 | ― | ||
| Adrian AllbonJarden | HoldReiterated | 08/24/26 | ― | ||
| Chris CooperJ.P. Morgan | BuyReiteratedNZD 53.96 | 08/24/26 | 11.16%Upside | ||
| Unknown AnalystMacquarieNot Ranked | BuyReiterated | 08/23/26 | ― | ||
| Shane StoreyCanaccord Genuity | BuyReiteratedNZD 45.38 | 05/27/26 | -6.51%Downside | ||
| Davinthra ThillainathanGoldman Sachs | BuyReiteratedNZD 53.21→NZD 54.83 | 02/23/26 | 12.96%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Fisher & Paykel Healthcare Corporation Limited
3 Months
Success Rate5/6 ratings generated profit
83%
Average Return
+16.38%
Copying Chris Cooper's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +16.38% per trade.
1 Year
Success Rate4/4 ratings generated profit
100%
Average Return
+19.82%
Copying Christine Trinh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +19.82% per trade.
2 Years
Success Rate5/5 ratings generated profit
100%
Average Return
+29.64%
Copying Davinthra Thillainathan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +29.64% per trade.
FPH Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 5 | 8 | 8 | 4 |
| Hold | 7 | 6 | 6 | 4 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 16 | 11 | 14 | 12 | 5 |
In the current month, FPH has received 4 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. FPH average Analyst price target in the past 3 months is 52.97.
FPH Financial Forecast
HighNZD 0.48
ConsensusNZD 0.46
LowNZD 0.41
FPH Earnings Forecast
Next quarter’s earnings estimate for FPH is NZD 0.46 with a range of NZD 0.41 to NZD 0.48. The previous quarter’s EPS was NZD 0.43. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighNZD 1.26B
ConsensusNZD 1.24B
LowNZD 1.2B
FPH Sales Forecast
Next quarter’s sales forecast for FPH is NZD 1.24B with a range of NZD 1.20B to NZD 1.26B. The previous quarter’s sales results were NZD 1.24B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
FPH Stock Forecast FAQ
What is NZ:FPH’s average 12-month price target, according to analysts?
Based on analyst ratings, Fisher & Paykel Healthcare Corporation Limited’s 12-month average price target is NZ$52.97.
What is NZ:FPH’s upside potential, based on the analysts’ average price target?
Fisher & Paykel Healthcare Corporation Limited has 9.12% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fisher & Paykel Healthcare Corporation Limited a Buy, Sell or Hold?
Fisher & Paykel Healthcare Corporation Limited has a consensus rating of Strong Buy, which is based on 6 buy ratings, 2 hold ratings and 0 sell ratings.
What is Fisher & Paykel Healthcare Corporation Limited’s share price target?
The average share price target for Fisher & Paykel Healthcare Corporation Limited is NZ$52.97. This is based on 8 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is NZ$56.88, and the lowest forecast is NZ$51.00. The average share price target represents a 9.12% increase from the current price of NZ$48.54.
What do analysts say about Fisher & Paykel Healthcare Corporation Limited?
Fisher & Paykel Healthcare Corporation Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 8 Wall Street analysts.
How can I buy shares of Fisher & Paykel Healthcare Corporation Limited?
To buy shares of NZ:FPH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
